VC Funds Starting with N

Neulogy Ventures, established in 2014 and based in Bratislava, Slovakia, is a Luxembourg-regulated venture capital fund. The firm focuses on early-stage tech companies, particularly those operating in Slovakia and the Central and Eastern Europe (CEE) region. Neulogy Ventures manages €65 million in assets, with a diverse portfolio spread across 10 countries. The fund targets investments in sectors like media, cleantech, data analytics, productivity applications, medtech, infrastructure, fintech, security, 3D, e-commerce, and new energy. Neulogy Ventures aims to support mission-driven entrepreneurs with bold ideas that push technological frontiers, particularly those addressing climate change and healthcare challenges. Neulogy Ventures emphasizes a hands-on approach, offering strategic guidance, business development support, and fundraising assistance to its portfolio companies. The firm values long-term partnerships, prioritizing shared values and a collaborative approach over quick exits. Notable companies in Neulogy's portfolio include GA Drilling, GreenWay, and GroupSolver. The team, led by managing partners Christian Mandl and Jaroslav Luptak, brings extensive experience in entrepreneurship, fundraising, and business development, ensuring robust support for their investees.

NeuroVentures Capital is a venture capital firm founded in 2000 and based in Charlottesville, Virginia, that claims to be the largest fund in the United States focused exclusively on the neuroscience space. The firm invests in companies developing drugs, medical devices, therapeutics, and technologies to treat central nervous system disorders including stroke, chronic pain, epilepsy, Parkinson's disease, and depression. NeuroVentures manages approximately $15 million and writes tickets ranging from $200,000 to $2 million, backing both development-stage and later-stage companies at seed, Series A, and Series B. The firm is led by Managing Director Mark Cochran, a PhD molecular biologist from Queen's University with postdoctoral training at the NIH, who previously served as VP of Business Development at Bayer Pharmaceuticals, founded MicroGeneSys Inc., and ran the San Francisco office of Toronto-based MDS Capital Corp. He is joined by Director Daniel O'Connell, who has operated multiple medical and healthcare startups. The firm's scientific advisory board includes Floyd Bloom of Scripps Research, Zach Hall (former director of NIH's National Institute of Neurological Disorders and Stroke), William Mobley of Stanford Neurology, and Donald Price of Johns Hopkins. NeuroVentures has made approximately 27 investments with four exits: one IPO — Acumen Pharmaceuticals, listed in July 2021 — and three acquisitions including Concentric Medical and Saegis Pharma. Other notable portfolio names include BrainCells Inc., which raised a $17.7 million Series A in 2005, EnVivo Pharmaceuticals, and Kadmus Pharmaceuticals. NeuroVentures Capital's singular focus on CNS diseases gives it scientific credibility and a curated network of neurologists, pharmacologists, and device engineers that few generalist life-science funds can replicate.

Neva SGR, founded in 2020, is the venture capital arm of Intesa Sanpaolo Group, one of Italy's largest banking institutions. Based in Turin, Neva focuses on investing in technology-driven companies at various stages, from seed to Series C. The firm is sector-agnostic but leans heavily towards fintech, deeptech, ESG transition technologies, and core tech innovations. With two main funds—Neva First and Neva First Italia—the firm targets both Italian and international startups. Neva First focuses on global opportunities, with a minimum of 30% invested in Italian companies, while Neva First Italia co-invests with a more localized emphasis on Italian startups. The funds have a combined budget of around €500 million, with an average ticket size of €4-10 million per investment. Neva SGR is particularly active in life sciences and deeptech, with notable portfolio companies including D-Orbit in space logistics and Tr1X, a biotech firm focused on autoimmune therapies. The firm’s mission is to foster innovation that addresses global challenges while boosting the Italian and European tech ecosystems.

NevCaut Ventures is a dynamic venture capital firm established in 2021 and headquartered in Irvine, California. Focused primarily on FinTech, NevCaut invests in pre-seed, seed, and Series A companies that are pushing the boundaries of financial technology to foster inclusivity and innovation. The firm prides itself on its ability to provide more than just capital, leveraging deep regulatory expertise and extensive networks in financial services to help startups navigate complex regulatory landscapes and scale effectively. With a portfolio that includes prominent companies like Upgrade, FairPlay, and Synctera, NevCaut Ventures targets businesses that offer solutions in financial services, business productivity software, and compliance management. The firm’s average investment ranges from seed rounds to early Series A funding, with several of its portfolio companies advancing to unicorn or "soonicorn" status. The leadership team, led by co-founders Dan Quan and Erik Brue, brings a wealth of experience from both the public and private sectors. Dan Quan, a former senior advisor at the U.S. Consumer Financial Protection Bureau (CFPB), played a significant role in driving fintech innovation and regulatory adaptation in the U.S. Meanwhile, Erik Brue offers deep expertise in data and technology, stemming from his extensive experience in company management and founding ventures. NevCaut's mission is to support ambitious founders who are creating impactful financial solutions for a more inclusive world, making it a key player in the rapidly evolving fintech landscape.

New Age Capital, founded in 2016 by Ivan Alo and LaDante McMillon, is a New York-based venture capital firm focusing on seed-stage investments in tech and tech-enabled startups led by Black and Latino entrepreneurs. The firm aims to bridge the funding gap for underrepresented founders by providing not only capital but also strategic guidance and access to a robust network of investors and partners. The firm typically invests between $850,000 and $1 million per company, targeting an ownership stake of 10-15%. New Age Capital prefers to lead funding rounds and maintains a hands-on approach, fostering long-term relationships with founders well in advance of their capital needs. This strategy allows the firm to provide tangible value and support through various growth stages. New Age Capital's portfolio includes a diverse array of companies such as Myavana, a personalized hair care recommendation platform; PredictionStrike, a sports stock market; and Navigate Maternity, which uses data to support prenatal and postpartum care. The firm's emphasis on authenticity, empathy, and transparency has positioned it as a trusted partner for founders from historically underfunded communities. By focusing on capital-efficient, high-potential startups in large and fragmented markets, New Age Capital aims to generate outsized returns while driving significant impact in the entrepreneurial ecosystem.

NAV.VC, formerly known as New Atlantic Ventures, is a venture capital firm based in Reston, Virginia. Founded in 1999, the firm has a strong focus on investing in seed and early-stage companies, particularly those operating in the technology sector. NAV.VC’s investment strategy centers around emerging and disruptive consumer trends, with key sectors including cybersecurity, digital health, fintech, e-commerce, education technology, and advertising technology. The firm is known for its hands-on approach, working closely with portfolio companies to help them navigate the challenges of early growth and scale their operations effectively. NAV.VC leverages its extensive network and deep industry expertise to provide strategic guidance, mentoring, and support to its portfolio companies, aiming to drive their success in highly competitive markets. NAV.VC’s portfolio features a diverse range of companies that are at the forefront of innovation in their respective fields. The firm has a track record of identifying promising startups with the potential to disrupt traditional industries and create significant value for both customers and investors. By investing in companies that align with emerging market trends, NAV.VC positions itself as a forward-thinking venture capital firm that is deeply committed to fostering innovation and supporting the next generation of tech entrepreneurs.

New Enterprise Associates (NEA) is a global venture capital firm with a storied history of supporting innovative businesses. Founded in 1977, NEA manages over $25 billion in assets and invests across all stages of a company's lifecycle, from seed stage to IPO. The firm has a diverse portfolio that spans technology and healthcare sectors. NEA's notable investments include companies like 23andMe, Coursera, Robinhood, and Uber, highlighting their focus on transformational businesses. They have facilitated over 270 IPOs and more than 450 mergers and acquisitions, underscoring their impact on the market. The firm operates from key locations in Menlo Park, California, and New York City, but their investment reach is global, covering North America, Europe, Asia, and beyond. NEA's strategy involves not just funding but also actively mentoring and supporting their portfolio companies through various stages of growth. Recently, NEA closed on two new funds totaling $6.2 billion, the largest in the firm's history, aimed at early-stage and growth-stage investments in sectors like enterprise tech, fintech, digital health, and life sciences. This reflects NEA’s commitment to driving innovation and supporting founders with the capital and expertise needed to build successful companies.

New Form Capital, established in 2019 and based in New York City, is a venture capital firm focused on the intersection of blockchain technology, capital markets, and financial data. The firm exclusively backs early-stage startups, with a strong emphasis on decentralized finance (DeFi) and blockchain infrastructure. New Form has made over 30 investments, supporting companies developing blockchain-driven financial services that aim to reduce inefficiencies and create new market opportunities. New Form typically writes its first checks during pre-seed and seed rounds, and its portfolio includes key players like Compound Finance and Blockfolio, which highlight the firm's deep expertise in decentralized finance. New Form leverages its extensive network of traditional finance institutions and fintech innovators to help its portfolio companies scale rapidly, providing both strategic guidance and connections to talent and follow-on capital. The firm’s founder and general partner, Alex Marinier, previously worked at DCM Ventures and Blackstone, bringing significant institutional investing experience to the table. Alongside a team of experts from venture capital, trading, and private equity, New Form positions itself as a key player in building the future of financial systems using blockchain​.

New Ground Ventures (NGV) is an early-stage, generalist venture capital firm founded in 2011 and headquartered in Palo Alto, California. The firm is one of the most active early-stage investors of the past decade, having funded roughly 145 companies since inception with more than 139 disclosed investments and 20 portfolio exits on record. NGV's portfolio clusters into three broad categories: software, consumer, and deep tech, spanning education, financial services, food and consumer brands, health, and enterprise software. The firm has raised at least two funds and operates with a small, highly experienced team anchored by Zac, who previously led the Principal Finance business at Silver Point Capital and was a partner there before co-founding NGV, and Anthony, formerly a managing director at Reservoir Capital focused on financial services, healthcare, and cleantech investments, and earlier an investor at Bain Capital Credit. NGV typically invests at pre-seed, seed, and Series A with checks of $100,000 to $3 million, running an efficient but rigorous diligence process focused on team quality, product and technology differentiation, unit economics, and cash flow relative to capital needs. The firm's flagship recent exit is Spindrift, the sparkling-water brand acquired by Gryphon Investors for a reported $650 million or more in January 2025. NGV's generalist posture is intentional — the firm believes that the characteristics that make a company an exceptional early-stage investment transcend sector, and that a flexible mandate allows it to follow conviction wherever the data leads. Operations are managed by Suzy, who oversees fund administration, investor reporting, and portfolio monitoring.

NLV Partners, founded in 2005, is a leading venture capital firm focused on revolutionizing healthcare. With notable investments in companies like CRISPR Therapeutics, Akili Interactive Labs, and iRhythm Technologies, NLV Partners targets biopharmaceuticals, diagnostics, medical devices, and healthcare IT. Their portfolio boasts 30 billion-dollar companies and numerous successful exits, reflecting their impact in the industry. Geographically, NLV Partners concentrates on the United States, partnering with businesses from startup stages to public offerings. Their investment strategy involves backing visionary teams and disruptive healthcare technologies. They aim to develop commercially attractive and clinically important healthcare solutions, leveraging decades of experience and deep domain expertise to navigate the complex healthcare landscape. NLV Partners typically leads investment rounds, providing not only capital but also strategic guidance. They prefer to be approached through well-prepared pitches that clearly demonstrate the potential for clinical and commercial success. The fund's average check size varies, tailored to the needs of each investment. The team includes co-founders Ron Hunt and Vijay Lathi, based in New York and Menlo Park respectively. Both bring extensive experience in healthcare investments and have been instrumental in shaping the firm's strategic direction. For startups seeking a partner with profound industry knowledge and a track record of success, NLV Partners stands out as a pivotal ally in the healthcare sector.

New Markets Venture Partners is a leading venture capital firm focused on education and workforce technology. They have invested in notable companies such as App Academy, Credly, and Galvanize, which provide innovative solutions to enhance education and career development. The firm emphasizes investments in companies that bridge gaps in education and the labor market, particularly those that impact at-risk populations in the U.S. Their primary investment areas include 21st-century skills, workforce preparation, alternative educational pathways, and the future of work. They seek growth-stage companies that have demonstrated product-market fit and scalable business models with high gross margins. New Markets typically invests at the Series A stage and beyond, with an average investment size ranging from $1M to $5M. Based in Fulton, Maryland, New Markets operates across the United States, focusing on impact-driven, evidence-based solutions. The team, led by co-founders Mark Grovic and Jason Palmer, brings decades of experience in institutional investing, with a strong network of strategic partners including foundations, non-profits, and corporations. New Markets Venture Partners prides itself on its mission-driven approach, supporting entrepreneurs through strategic guidance, operational advice, and introductions to a vast network of industry leaders and potential partners. They are particularly interested in companies that demonstrate efficacy in their solutions and have a clear path to significant social impact​.

New Money Ventures is a venture capital firm dedicated to transforming the future of consumer goods and wellness by investing in purpose-driven brands. Led by CEO and founder Jaclyn Johnson, the firm focuses on early-stage startups that are redefining their respective industries through innovation and impact. New Money Ventures primarily targets companies in the beauty, health, wellness, and consumer tech sectors. With a mission to empower underrepresented founders, particularly female and diverse entrepreneurs, the firm actively looks for startups that emphasize sustainability, inclusivity, and social impact. Their investment strategy is not just financial; they offer mentorship, strategic guidance, and access to a broad network of resources to help founders scale their businesses effectively. The firm has invested in brands like OUAI Haircare, Doe Lashes, and INBLOOM, reflecting its commitment to backing companies that prioritize both purpose and profit. New Money Ventures also stands out for its focus on creating long-term partnerships with founders, ensuring that the startups they support have the resources and guidance necessary to thrive in highly competitive markets.

New North Ventures is a venture capital firm focused on early-stage investments in technologies critical to national security and economic resilience. Founded in 2019, the firm specializes in sectors like AI/ML decision-making, cybersecurity, and technologies designed to combat misinformation. New North Ventures is dedicated to supporting companies at the intersection of defense, intelligence, and critical infrastructure, with the goal of advancing innovations that align with the national interests of the U.S. and its allies. Their investment strategy typically targets companies from Pre-Seed to Series A stages, with investment sizes ranging from $1M to $3M. New North Ventures often seeks a 10% equity stake in the companies they back. The firm is also notable for its strong ties to government entities, such as the Office of Strategic Capital and the Small Business Administration, which enhance their ability to support and scale dual-use technologies. The firm operates out of Manchester, New Hampshire, and has been involved in several high-impact investments, including companies like Reality Defender and Efabless. Their latest fund, New North Ventures Fund II, is structured to leverage both private and government capital, aiming to deliver substantial returns while supporting innovations crucial to national security.

VisVires New Protein, recently rebranded as Clay Capital, is a Singapore-based venture capital firm dedicated to transformative investments in the agrifood tech sector. Founded in 2014, Clay Capital focuses on supporting innovative startups that address fundamental challenges in the food system, particularly in the areas of sustainable packaging, fermentation, agricultural biologicals, crop disease resistance, soil health, and regenerative agriculture. Notable investments include French biostimulant producer Toopi, Israeli bioherbicide startup WeedOUT, and French kitchen robot manufacturer Cook-e. These investments reflect Clay Capital's commitment to leveraging technology to improve sustainability and efficiency in the food and agriculture sectors. Clay Capital's strategy involves investing in early-stage to growth-stage startups, typically with initial checks ranging from $3 million to $8 million, and reserving additional capital for follow-on investments. The firm serves as a bridge between the Asian and European markets, providing startups with support to access and expand in these regions. The rebranding from VisVires New Protein to Clay Capital signifies a renewed focus on building a healthy and sustainable food system, symbolizing fertile ground for growth and innovation. With a newly raised $145 million fund, Clay Capital is well-positioned to continue driving impactful changes in the agrifood tech landscape

New Richmond Ventures (NRV) is a venture capital firm founded in 2011 and headquartered in Richmond, Virginia, created by a group of prominent Richmond-area business, investment, and philanthropic leaders. Co-founders include Jim Ukrop, former CEO and Chairman of Ukrop's Supermarkets and Chairman of First Market Bank; Bob Mooney; and Ted Chandler, formerly Chairman and CEO of a Fortune 500 financial services company. Laura Markley serves as Chief Financial Officer and Managing Director. The firm has raised approximately $36.5 million across three funds, including a $30 million Early Stage Growth Fund raised in 2016. NRV invests primarily at Series A and follows on through later rounds across healthcare, food and beverage, and e-commerce — sectors where the team's deep local and national operating network delivers tangible value. The firm has made approximately 21 portfolio investments across its funds with 4 exits and additional acquisitions among legacy portfolio names including Summit Materials, Health Warrior, and Envera Health. Active portfolio companies include Murphy's Naturals, a natural insect repellent brand that raised an $8.5 million Series A in April 2022 alongside 550 Capital Partners; SVT Robotics, a warehouse robotics orchestration platform that raised a $3.5 million seed in May 2020 with Cowboy Ventures; and Farmer Focus (also known as Shenandoah Valley Organic), an ethically raised poultry brand that raised a $15 million round in December 2019. NRV's founding thesis targets social-impact entrepreneurs tackling societal megatrends, and the firm provides portfolio companies with structured mentoring, cross-industry exit partner introductions, and a toolkit built from decades of Richmond-area business leadership. The firm's Virginia bias is a feature — it gives NRV consistent access to mission-aligned founders outside the coastal startup mainstream.

New Science Ventures (NSV) is a premier venture capital firm established in 2004, with offices in New York and London. The firm specializes in investing in companies that leverage groundbreaking scientific innovations in the life sciences and information technology sectors. NSV has a keen focus on businesses with strong IP protection and those addressing significant unmet market needs. Notable investments include Ventyx Biosciences, Phase Four, Achronix Semiconductor, and Paragraf. NSV is particularly interested in companies that can transform their industries with innovative scientific approaches. Their strategy is to invest in both early and mid-stage companies, supporting them through crucial growth phases to maximize their potential and value. NSV is not afraid to take contrarian views and often seeks opportunities outside traditional tech hubs, emphasizing the importance of science-based innovation. The firm typically leads funding rounds and provides substantial follow-on support, ensuring that their portfolio companies have the resources needed to succeed. Key team members include co-founder Tom Lavin, who brings over 30 years of experience in finance and investment banking, and Raju Mohan, a seasoned biotech entrepreneur and senior advisor with extensive expertise in drug discovery and development. Startups looking to engage with NSV should emphasize their scientific uniqueness and potential for significant market impact. NSV values strong management teams and clear, defensible IP strategies, making these essential points of focus when approaching the firm.

NewSpace Capital is a space-focused venture capital firm that invests in growth-stage companies at the intersection of space technology and sustainable development. With a focus on scalable technologies and established revenues, NewSpace targets businesses that leverage space applications to address critical global challenges, including climate change, environmental monitoring, and resource management. The firm typically invests between €10 to €20 million in companies that are ready to scale their operations, offering both financial support and strategic expertise. NewSpace Capital operates with a “picks & shovels” strategy, concentrating on key areas like satellite communications, earth observation, remote sensing, advanced analytics, and space infrastructure. Their approach minimizes risk by backing companies that have moved beyond technical and market entry barriers, ensuring they are poised for significant growth. Portfolio companies like ICEYE, which specializes in Synthetic Aperture Radar (SAR) technology for earth observation, and Kayrros, a leader in environmental intelligence, highlight NewSpace’s commitment to leveraging space technology for tangible impacts on Earth. The firm is led by a team of multidisciplinary experts with deep industry connections, allowing them to access exclusive deals in underinvested segments of the space market. With a target fund size of €250 million, NewSpace Capital aims to drive the next wave of innovation in space while addressing pressing global issues, positioning itself as a key player in the rapidly expanding space economy.

NewSpring Capital, founded in 1999 and headquartered in Radnor, Pennsylvania, is a private equity firm focusing on growth equity, mezzanine capital, healthcare, and buyouts. The firm manages approximately $3.5 billion in assets and has invested in over 250 companies across various sectors. Notable investments in NewSpring's portfolio include Vacasa, a leading vacation rental management company; Innovid, a video marketing platform; and Nutrisystem, a weight management company. These investments reflect NewSpring's strategy of supporting high-growth companies in business services, healthcare, information technology, and consumer products. NewSpring Capital operates through multiple strategies, including NewSpring Growth, which targets high-growth technology companies; NewSpring Healthcare, focusing on innovative healthcare services and technology; and NewSpring Mezzanine, providing capital for acquisitions and recapitalizations. The firm's comprehensive approach allows them to support companies at different stages of their lifecycle, from early growth to expansion.

New Stack Ventures is an early-stage venture capital firm focused on investing in founders who are often overlooked by traditional venture capital firms. Founded by Nick Moran, New Stack Ventures targets startups in under-capitalized markets and geographies, with a particular focus on IoT, deep tech, smart hardware, and various platform-based business models. The firm recently closed its second fund, New Stack Ventures Fund II, at $42.6 million, significantly larger than its first $6 million fund. This new fund allows New Stack to support an additional 35 companies at the pre-seed and seed stages. The firm prides itself on being one of the largest single-partner funds raised outside of the typical Silicon Valley ecosystem, emphasizing its commitment to backing "outsider" founders. New Stack Ventures has built a strong reputation for its proactive and founder-friendly approach. The firm was highlighted by TechCrunch as one of the most active and engaged investors in the industry. Its portfolio includes notable companies like Draftbit, Curv, and Flamingo, reflecting its diverse investment strategy. The team at New Stack Ventures is comprised of experienced professionals, including Nate Pierotti, Luke Skertich, and Ariella Frank, who bring extensive backgrounds in startups, product management, and venture capital. Their collaborative and inclusive investment process ensures they identify and support high-potential startups effectively.

The Edward L. Kaplan, '71, New Venture Challenge (NVC) is a startup accelerator and investment program run by the Polsky Center for Entrepreneurship and Innovation at the University of Chicago Booth School of Business, founded in 1996 in Hyde Park, Chicago. The NVC is consistently ranked among the top university-based business-plan competitions and accelerators in the nation, placing alongside Y Combinator and Techstars in the Seed Accelerator Rankings Project. Since inception, more than 230 NVC-backed startups remain in operation, having collectively raised over $915 million in follow-on capital and generated more than $13 billion in exits. The program is led by Polsky Center Executive Director Starr Marcello, with deep adjunct faculty involvement from Mark Tebbe. The NVC operates multiple tracks: the flagship graduate program, a Social NVC in partnership with the Rustandy Center for Social Sector Innovation, a Global NVC for Executive MBA students, a College NVC for undergraduates, and an Alumni NVC launched in 2018 for UChicago graduates worldwide. The 29th annual competition in June 2025 awarded a record $2.267 million to ten finalists — the largest prize pool in the history of any university-based business-plan competition — with B2B SaaS company Rayni taking first place and $835,000. Other 2025 finalists included NutraCareU, MOOJ, and relos. Prizes typically range from seed grants of a few thousand dollars up to six-figure investments. Breakout NVC alumni include Grubhub, the 2006 winner that completed an IPO; Simple Mills, the 2014 winner acquired by Flower Foods for $795 million; and Braintree. The program has become a material generator of venture-backed companies from the University of Chicago community.

New Venture Partners is a global venture capital firm that specializes in transforming corporate R&D assets into standalone businesses. The firm focuses on leveraging cutting-edge innovations from large technology companies and spinning them out into independent ventures. With a unique approach, New Venture Partners works closely with corporate partners to identify high-potential technologies that may not align with the company's core business but have significant market opportunities. The firm invests primarily in sectors such as telecommunications, IT, semiconductors, and digital media, emphasizing deep tech and transformative innovations. Their portfolio includes companies that emerged from major R&D labs, such as Bell Labs and British Telecom, showcasing their expertise in corporate spinouts. New Venture Partners typically invests in early-stage startups, guiding them from the incubation phase through to commercialization. Their team brings a wealth of experience from both the corporate and entrepreneurial worlds, providing a mix of strategic guidance and operational support to help ventures scale. With offices in the U.S. and Europe, New Venture Partners has a global reach and focuses on markets across both continents. Their strategy revolves around aligning with corporate partners to unlock the commercial potential of underutilized technologies, ultimately creating high-value businesses that deliver strong financial returns. The firm has established a reputation as a leader in corporate venture capital, with a track record of successful exits and long-term value creation.

New Wave Ventures is a dynamic, privately-owned venture capital fund based in London. Focused on investing in companies with significant growth potential, New Wave targets initial investments ranging from £500,000 to £2,000,000. Unlike many funds, New Wave Ventures invests its own capital without relying on external investors, allowing for a more flexible and long-term investment approach. Their investment philosophy centers on the belief that great businesses are built by great people. New Wave Ventures seeks entrepreneurs who can overcome obstacles and dominate their markets on a global scale. They prefer to co-invest with like-minded partners but often opt to be the sole investor alongside committed owner-managers. This fund is not driven by short-term exits or leverage; instead, it focuses on sustainable growth and strategic support​. Geographically, New Wave Ventures concentrates on the UK, particularly the North West region, encompassing cities like Manchester and Liverpool. Their goal is to fill the funding gap for early-stage and scale-up businesses in these areas, fostering innovation and growth​. The leadership team at New Wave brings a wealth of experience in running successful businesses and tackling various challenges. Their approach involves minimal interference in day-to-day operations, instead offering strategic guidance and financial support. Startups can reach out directly via email for potential investment opportunities​. This combination of substantial financial backing, strategic expertise, and a people-first philosophy makes New Wave Ventures a compelling partner for ambitious entrepreneurs looking to scale their businesses.

New York Angels, founded in 2004, is one of the most active and well-established angel investor groups based in New York City. Specializing in early-stage investments, the group has made over 386 investments, with notable successes including Greenhouse Software, Payoneer, and Billtrust. Their portfolio spans various sectors such as Artificial Intelligence, Fintech, Healthcare, and SaaS. New York Angels typically invests in increments starting from $25,000 and expects its members to invest a minimum of $50,000 annually in its deals. Their average investment round size is around $2 million, and they are known for both leading and participating in follow-on rounds. The group has achieved 72 exits, indicating a strong track record of identifying and nurturing high-potential startups. The investment strategy of New York Angels emphasizes thorough due diligence and a collaborative approach, leveraging the diverse expertise of its members. They actively engage with their portfolio companies, providing not only capital but also valuable mentorship and networking opportunities. Key figures in the organization include founder David S. Rose, who has played a pivotal role in shaping the group's investment philosophy and operations. Startups looking to secure funding from New York Angels should be prepared to demonstrate strong business fundamentals and a clear growth trajectory

New York Life Ventures (NYL Ventures) is the corporate venture capital arm of New York Life Insurance Company, founded in 2012 and headquartered in New York City. The unit was launched by Joel Albarella, Senior Vice President and Head of NYL Ventures, who is regarded as one of the insurance industry's earliest and most prominent corporate venture capitalists. NYL Ventures started with approximately $200 million in committed capital and has grown to roughly $1.2 billion in assets under management, delivering a 10-year internal rate of return of nearly 30% and top-quartile returns since inception. At its 10-year milestone the fund had crossed $1 billion in AUM and completed more than 250 proof-of-concept tests with portfolio companies. NYL Ventures invests from seed to growth stages, with checks ranging from $1 million to more than $10 million, concentrating on fintech, insurtech, enterprise software, digital health, and proptech. The investment team includes Tim Del Bello as Head of Investments, John Masson as Director, and Senior Associates Madison Cuthbertson and Alan Day. The fund has executed more than 65 VC investments, maintaining an active portfolio of roughly 34 companies including 4 unicorns. Notable investments include Norm Ai, a regulatory-AI platform that raised a $27 million Series A in 2024; ValidMind, a model-risk management platform that raised an $8.1 million seed; Empathy, a bereavement platform that raised a $47 million Series B and became NYL's first insurance-industry partnership; and Scribe, a $25 million round participant. NYL Ventures functions as a strategic as well as financial partner, offering portfolio companies direct access to New York Life's distribution capabilities, actuarial expertise, and relationships across the insurance and wealth management industry.

New York Venture Partners, founded in 2014, is a venture capital firm based in New York City. NYVP focuses on early-stage investments, particularly in seed rounds, and aims to support startups with both capital and strategic guidance. The firm has a diverse portfolio with investments across various industries, including enterprise software, cybersecurity, AI, fintech, and health tech. NYVP is known for its notable investments in companies like VHX, Food52, and CrowdTwist, which have achieved significant market success. The firm typically invests check sizes ranging from $300,000 to $700,000, allowing it to support startups through critical early development phases. NYVP's investment strategy emphasizes partnering with innovative entrepreneurs and providing them with resources beyond just financial support. This includes access to experienced advisors who can offer strategic guidance, as well as operational support to help with recruiting and fundraising efforts.

Empire State Development (ESD) is New York State's chief economic development agency, focusing on promoting business growth, job creation, and enhancing the state’s overall economy. Through various programs and initiatives, ESD supports businesses of all sizes and industries, providing financial incentives, grants, loans, and other resources to foster economic development across the state. One of ESD's flagship programs is the "FAST NY" initiative, which aims to create shovel-ready sites for industrial development, providing substantial grants to improve infrastructure like transportation, utilities, and site development. This program has committed over $175 million to support over 2,700 acres of industrial property. ESD is also a major player in fostering innovation through investments in life sciences and biotech. For instance, the expansion of Harlem Biospace, supported by a $1.5 million ESD grant, exemplifies its role in nurturing New York’s biotech ecosystem by providing advanced facilities for startups and fostering collaboration between businesses and academic institutions like Columbia University. Overall, ESD’s initiatives are focused on strategic job creation, attracting innovative industries, and revitalizing communities, helping to position New York as a competitive environment for both startups and established businesses.

Newark Venture Partners is a seed-stage venture capital firm based in Newark, New Jersey, with a strong focus on B2B software companies. Founded in 2015, NVP aims to support innovative startups by providing seed funding and operational support to foster growth and success. The firm has raised approximately $90 million for its second fund, doubling the size of its first fund. NVP's investment strategy revolves around healthcare, fintech, and supply chain sectors, seeking startups that offer transformative solutions in these high-stakes industries. The firm’s portfolio includes notable companies like Podsights, Optimal Dynamics, and Handspring Health, highlighting their commitment to driving innovation in enterprise software. The team at NVP is led by Managing Partners Tom Wisniewski, Dan Borok, and Vaughn Crowe, who bring extensive experience in venture capital and entrepreneurship. The firm is known for its active involvement in the Newark community, including partnerships with organizations like the Boys and Girls Club of Newark and Braven, which support local talent and promote educational and employment opportunities.

NewBuild Venture Capital, founded in 2022 and headquartered in Palo Alto, focuses on early-stage investments in supply chain technology, logistics, AI, and cloud infrastructure. The firm employs a thematic investment approach, concentrating on the transformative impact of technologies like generative AI, machine learning, and edge computing on enterprise productivity and supply chains. By targeting innovative companies that address challenges from procurement to logistics and warehouse automation, NewBuild aims to create more resilient and sustainable supply chain solutions. NewBuild’s portfolio includes companies such as OnRamp, which focuses on automating freight payments, and Drumkit, which uses AI to streamline logistics operations. The firm’s hands-on approach is supported by an experienced team, including managing partner Rohini Chakravarthy and venture partner Madhav Durbha, who bring decades of expertise from leading roles at companies like Google Cloud, Databricks, and Project44​. Through deep industry connections and a keen understanding of technological trends, NewBuild positions itself as a key player in shaping the future of enterprise supply chain and infrastructure software.

NewDo Venture is a cross-border US-China early-stage venture capital firm founded in 2015 and headquartered in Palo Alto, California, with additional offices in San Mateo and New Haven and team presence in China. The firm explicitly bridges the gap between the United States and Chinese technology markets, backing 'fearless founders' through its angel and growth funds and a hands-on support infrastructure that covers HR, financial management, business process, and legal affairs across both countries. NewDo is led by Managing Partner Jingyuan Wang alongside a team of roughly eight, including six partners, one venture partner, and one principal distributed across the US and China. The firm concentrates on AI, enterprise services, healthcare, cloud computing, SaaS, mobile applications, IoT, computer vision, VR/AR, and education. It primarily writes Series A checks, with investment sizes reported up to approximately $11 million per deal. NewDo has invested in approximately 36 companies, producing 1 unicorn, 2 IPOs, and 5 acquisitions. The standout portfolio name is Rippling, the workforce management platform that NewDo backed at Series A in March 2017 — before the company reached unicorn status in 2020 and a $16.8 billion valuation by May 2025. Other portfolio companies include Lyft, which completed an IPO; BillionToOne, a genetic diagnostics company that was acquired; and ObEN, an AI-powered avatar platform. The most recent disclosed exit was Garten in April 2025. NewDo's cross-border positioning gives it a structural sourcing edge: it can identify exceptional Chinese-origin founders building globally relevant companies and connect US-founded portfolio companies with Chinese enterprise customers, manufacturing partners, and capital markets.

Newfund Capital, founded in 2008, is an entrepreneurial venture capital firm with a strong presence in both Paris and Silicon Valley. With $300 million in assets under management, Newfund focuses on seed-stage startups driving global change. Notable investments include Aircall, Fairmoney, and In2Bones, showcasing their diverse and impactful portfolio. The firm invests primarily in technology, precision medicine, personalized treatment, and brain tech sectors. They emphasize early-stage investments, aiming to support startups from the seed stage through international expansion, particularly in France and North America. Newfund's strategy involves quick decision-making, often providing term sheets within three weeks. They seek entrepreneurs with a global mindset and provide significant value beyond capital, including scaling opportunities, networking, and strategic support. The average check size varies but is tailored to meet the needs of each startup, with Newfund often leading the investment rounds. The team includes key members like Henri Deshays and Patrick Malka, who bring extensive entrepreneurial and investment experience. The team is split between their Paris and Palo Alto offices, allowing them to maintain a strong presence in both Europe and the U.S. For startups looking to scale rapidly with a partner who understands the entrepreneurial journey, Newfund Capital offers a compelling blend of expertise, resources, and strategic guidance.

Newgen Venture Partners is a global angel and seed fund platform founded in 2012 and headquartered in Shanghai, China, with additional offices in Beijing, Hong Kong, and Palo Alto. The firm backs entrepreneurs working in life science and information technology with the most innovative ideas and disruptive technologies, explicitly targeting world-class management and technical teams pursuing disruptive opportunities across TMT, life science, and emerging technology. Newgen is led by Founder and Managing Partner Lu Zhang, who has built the firm into a portfolio of more than 100 companies with accumulated valuations exceeding RMB 50 billion (approximately $7 billion). Newgen leads rounds and is often the first institutional investor in its portfolio companies, writing early seed checks of $100,000 to $3 million. Notable portfolio companies include GrubMarket, a US online grocery and food supply-chain platform that received Newgen's first check at seed in January 2015 and most recently raised a $50 million Series H at a $4.5 billion pre-money valuation in February 2026; HotMaxx, a Chinese food and fast-moving-consumer-goods discount retailer; LePure, a Chinese biotech; and WePie. Portfolio exits include Kheiron Medical Technologies, an AI radiology company acquired by DeepHealth in October 2024, and Paperspace, a cloud GPU infrastructure company. In 2025 to 2026, Newgen led the undisclosed Series A of TuCodec alongside Angel Bay Ventures and MFund. Beyond direct investing, Newgen Capital operates as a limited-partner arm, backing emerging VC funds such as ZPARK Venture and GSR Ventures vehicles, positioning the firm as a platform that accelerates the broader early-stage ecosystem rather than purely deploying direct capital.

Newid Capital is a U.S.-based venture capital firm with a unique focus on investing in financial services companies that target underserved populations in emerging markets. The firm primarily backs early-stage startups and typically invests in sectors like fintech and agricultural technology, with an emphasis on companies that provide critical services to underbanked communities across Africa, Asia, and Latin America. Notable investments include Lidya, a Nigerian fintech platform, CreditMantri in India, and Apollo Agriculture in Kenya, demonstrating their commitment to scalable financial inclusion solutions. Founded in 2014, Newid Capital takes a collaborative approach, often co-investing with other impact-focused funds like Accion Venture Lab and Bamboo Capital Partners. The firm generally participates in seed and early-stage rounds, with typical check sizes ranging from $700K to $6M. They are known for their hands-on involvement, leveraging their expertise to help portfolio companies grow strategically, especially in areas where financial infrastructure is underdeveloped. The firm is led by Ainsley Cohen, who brings extensive experience in finance and impact investing. Cohen is based in Alexandria, Virginia, where Newid Capital is headquartered, and the firm maintains a lean operational structure, focusing more on impact than on leading rounds. They prefer to work with mission-driven entrepreneurs and are highly selective about their partnerships, prioritizing long-term change over short-term gains. For startups looking to engage Newid Capital, demonstrating a strong social mission with measurable impact is key.

Newion is a pan-European early-stage venture capital firm based in Amsterdam, specializing exclusively in business software. Since its founding in 2000, Newion has invested in over 60 startups, helping companies like Collibra, Deliverect, and Foleon emerge as market leaders in their sectors. Their primary focus is on innovative B2B software companies within the Benelux, Nordics, and Germany. Newion's investment strategy involves participating in seed rounds and Series A funding, providing both capital and hands-on support to help startups scale. The firm manages a total of €300 million in assets across several funds, with their latest, Newion IV, launching with an initial closing of €130 million. The Newion team includes seasoned professionals such as Patrick Polak and Frank Claassen, who bring extensive experience in venture capital and corporate finance. Their approach is characterized by a no-nonsense mentality and a deep commitment to helping their portfolio companies achieve significant growth and market leadership.

Newpath Partners is a Boston-based venture capital firm specializing in life sciences. Founded in 2018 by Dr. Thomas Cahill, Newpath focuses on building biotechnology companies from the ground up, partnering with leading academic scientists to translate groundbreaking scientific discoveries into transformative therapies. With a strong commitment to high-impact ventures, the firm is particularly known for its deep involvement in the early stages of company formation, often acting as a founding investor. Newpath Partners manages multiple funds, with its second fund, raised in 2021, amounting to $350 million. This fund continues Newpath’s mission to back companies with high scientific originality and ambitious goals, particularly in areas like regenerative medicine, genomics, and oncology. The firm typically invests in early-stage ventures, providing not only capital but also strategic guidance and access to a network of industry leaders. Dr. Cahill, who also founded the nonprofit Scientists to Stop COVID-19, leads a team that is highly experienced in both science and business, ensuring that the companies they back are well-positioned to make a significant impact in the life sciences arena. Newpath’s approach is characterized by a close collaboration with founders, aligning interests across scientists, investors, and management teams to drive innovation and success.

NewSchools Venture Fund is a 501(c)(3) nonprofit venture philanthropy organization founded in 1998 by Kim Smith, John Doerr of Kleiner Perkins, and Brook Byers, headquartered in Oakland, California. NewSchools is the first and only venture philanthropy focused exclusively on K-12 education: it raises charitable donations and grants them to early-stage entrepreneurs and educators reimagining public education, with particular attention to students from underserved communities. Since founding, the fund has directed nearly $345 million to more than 1,000 education ventures, activists, and policy advocates, including more than $150 million to over 300 charter schools between 1999 and 2015 that collectively served 157,000-plus students. CBInsights counts 92 direct investments. The fund is currently led by CEO Frances Messano, who succeeded long-serving CEO Stacey Childress effective January 2023. The board includes founders Smith, Doerr, and Byers alongside Stacey Childress, Ime Archibong, and others. NewSchools deploys one-year unrestricted grants of $150,000 to $250,000 along with one-on-one coaching and peer-community support across four investment areas: Innovative Schools, Learning Solutions (K-8 literacy and math including AI-powered personalized learning), Teaching Reimagined (AI-assisted teacher productivity), and Learning Differences. In 2024 the fund announced more than $23 million in new and follow-on investments to 80-plus ventures selected from 1,600 applicants; in October 2025 it announced an additional $10 million-plus to accelerate teaching and learning innovation. NewSchools has spun out several notable initiatives, including Reach Capital, the EdForward DC and Educate78 advocacy organizations, and the NewSchools Ignite edtech accelerator. The fund's three-decade track record makes it the deepest-rooted source of philanthropic venture capital in American K-12 education.

Newton Biocapital is a Brussels-based venture capital firm with a strong presence in both Europe and Japan, focusing exclusively on the life sciences sector. Established in 2017, the firm’s investment strategy is centered on supporting companies that tackle chronic diseases, with an emphasis on oncology, metabolic diseases, and neurological conditions. Newton Biocapital plays a hands-on role in its portfolio companies, often leading funding rounds and taking board positions to guide scientific and clinical strategies​. The firm manages two funds—Newton Biocapital I (€114M) and Newton Biocapital II, which is currently targeting €150M. NBC I invested in 14 companies across Europe and Japan, including university spin-offs like Epics Therapeutics and ChromaCure in Belgium, and biotech firms like EditForce in Japan. Newton's approach is deeply integrated with the local ecosystems in both regions, leveraging their strong ties to academic institutions, industry experts, and international investors to facilitate cross-border growth and exits​. Newton’s team combines scientific, regulatory, and investment expertise, led by CEO Alain Parthoens. With offices in Brussels and Tokyo, they are uniquely positioned to bridge the innovation pipeline between Europe and Japan, driving impactful advancements in life sciences​.

NewTribe Capital is a Dubai-based venture capital firm primarily investing in early-stage Web3, blockchain, and AI startups. With a portfolio exceeding 200 projects globally, including sectors like DeFi, gaming, infrastructure, and NFTs, NewTribe actively fosters innovation in the digital space. Some notable investments include Cookie3 and KIP, with an average check size around $200,000. The firm focuses on building long-term partnerships, often providing advisory services such as market-making, growth hacking, and smart contract auditing, to ensure the success of its portfolio companies​. Geographically, NewTribe targets the MENA region, but also extends investments into Europe, Asia, and beyond. Its strategy emphasizes infrastructure development that bridges Web2 and Web3, alongside token-based and equity investments. Notably, NewTribe backs projects aligning with Dubai’s Web3 initiatives, offering support through accelerator programs and partnerships. Led by partners such as Dhaval Parikh and Juliet Su, NewTribe’s team combines technical expertise with deep industry connections. For startups seeking funding, NewTribe looks for founders with strong visions in blockchain or AI, particularly those aiming to create large-scale digital infrastructure.

Newzone Ventures is a pan-European early-stage venture capital fund headquartered in Lisbon, Portugal, with an office in London, formed in 2021 through the merger of UK-based Newzone and Portugal-based LC Ventures. The firm is led by Managing Partners David Boulton and Pedro Falcao, supported by a lean team of approximately four distributed across Portugal and the United Kingdom. At the time of the merger the combined platform brought together a portfolio of roughly 40 tech startups and more than $30 million in discretionary capital; the firm subsequently earmarked a new $60 million fund to target overlooked markets and founders across Europe. Newzone invests primarily at pre-seed and seed into Portugal- and UK-based startups building technology-led, category-defining, and sustainable businesses, writing checks from $100,000 to $3 million. The firm's three pillars — founder focus, tech-enabled, and sustainable — reflect a conviction that durable businesses require long-term collaborative capital, meaningful product differentiation, and business model resilience. Partners bring two decades of institutional investing and operating experience and have been involved with companies including WeJo, Hero (acquired by Klarna), GitLab, and Feedzai, Portugal's fintech unicorn. As of early 2023 the firm had made approximately 30 disclosed investments. Notable current portfolio companies include Networkme, with an average round investment of approximately $992,000; Visor.ai, a conversational AI platform; and Universal Cover. Newzone Ventures positions itself as an open and transparent partner, offering founders practical advice on development, operations, and team building alongside capital. The firm's dual-city presence across Lisbon and London gives it coverage of two of Europe's most active startup ecosystems.

Nexit Ventures is Finland's oldest and most experienced technology growth capital firm, founded in 1999 and headquartered in Helsinki with a deep presence in Silicon Valley and ecosystem connections into Austin, Texas. The firm describes itself as a Nordic and Transatlantic 'Activist VC' focused on digital transformation, investing primarily in later-stage B2B software and technology companies where its historical success ratio has been close to 80% — well above industry averages. Nexit was co-founded by Artturi Tarjanne, who brings more than 30 years of international IT experience and is one of Finland's pioneering software entrepreneurs, alongside Michel Wendell, Pekka Salonoja, and Risto Siilasmaa — the latter being the former Chairman of Nokia. Current partners also include Sami Karppinen and Risto Yli-Tainio. Nexit manages three fund vehicles totaling roughly EUR 173 million in direct capital, plus a EUR 110.8 million joint operation with 3TS Capital Partners formalised in October 2021: Nexit Infocom 2000 (EUR 66.7 million), Nexit Infocom II (EUR 85 million), and Nexit III (EUR 21.6 million). The firm has made 44 total investments, currently manages 22 active portfolio companies, and has produced 12 exits including acquisitions by Google, Hewlett-Packard, and Nvidia. By geography the portfolio is concentrated in the United States (9 investments) and Finland (6). Notable portfolio companies include Boksi Solutions, which received a Series A follow-on in October 2023; Funambol; Aava Mobile, exited in September 2021; and Aino Health AB, in which Nexit III purchased a 29% stake. Nexit's Activist VC model means the firm takes an unusually engaged role — working directly on strategy, commercial development, and team building alongside portfolio management teams rather than limiting its contribution to board oversight.

Next 10 Ventures, founded in 2018 by former YouTube executive Ben Grubbs, is a venture firm dedicated to the global creator economy. Headquartered in Los Angeles and Singapore, the firm focuses on early-stage investments and incubation of businesses within the digital content space. With a $50 million fund, Next 10 Ventures supports startups that offer tools and services for content creators, such as GoMeta, which helps design interactive experiences, and SuperBam, a digital rights management firm. The firm’s average investments range from $250,000 to $500,000. Next 10 Ventures specializes in creator-driven businesses in areas like education, entertainment, and entrepreneurial ventures. Their investment strategy targets creators looking for long-term growth, avoiding short-term "money-grab" opportunities. The firm also provides substantial operational support, including crafting business models for creators, many of whom lack formal plans. The team, including hires like Lauren Schnipper, formerly of Facebook, is spread across key creative hubs like Los Angeles and Singapore, with plans to scale in regions with high creator activity. The firm looks for creators who fit into categories such as artists, entrepreneurs, and educators, while prioritizing sustainability and community impact​.

Next Coast Ventures, established in 2015 and headquartered in Austin, Texas, focuses on investing in high-growth startups located outside traditional coastal tech hubs. The firm targets early-stage investments, particularly in emerging platforms, enterprise solutions, and consumer-focused businesses. Notable companies in their portfolio include Everly Health, Enboarder, and Diligent Robotics, reflecting their commitment to innovative and transformative technologies. Next Coast Ventures employs a thematic research approach, identifying key investment themes rather than focusing on specific sectors. This allows them to partner with "glass-eating" entrepreneurs—founders who are resilient and driven to build category-defining companies. Their investment strategy is characterized by active involvement, with partners often taking board seats and providing strategic guidance to help portfolio companies scale rapidly. The firm has made 159 investments to date and has successfully exited several companies, including Stoplight and AlertMedia. Founders Michael Smerklo and Thomas Ball lead a team of experienced investors who bring deep industry knowledge and a hands-on approach to their portfolio companies. Startups seeking to partner with Next Coast Ventures should demonstrate strong growth potential and alignment with the firm’s thematic investment focus. The firm’s recent investments, such as in Diligent Robotics and Everly Health, showcase their interest in companies that leverage technology to solve significant problems in healthcare, enterprise software, and consumer markets​.

Next Frontier Capital, founded in 2015 and headquartered in Bozeman, Montana, is an early-stage venture capital firm that partners with mission-driven entrepreneurs in the Rocky Mountain region. The firm focuses on investments in B2B technology and deep tech companies at the Seed and Series A stages. They manage four funds, with the latest being Fund IV, and typically invest between $2 to $10 million per round​. Next Frontier Capital emphasizes supporting the underserved Rocky Mountain startup ecosystem. Their portfolio includes companies like Submittable, Bridger Photonics, and Claravine, reflecting their commitment to high-impact technology ventures​​. The firm values diversity, intellectual rigor, and a strong connection to the region, aiming to create long-lasting companies that contribute significantly to their communities​. The team at Next Frontier Capital, led by founders Will Price and Richard Harjes, brings extensive experience from both venture capital and operational roles. They provide hands-on support to their portfolio companies, leveraging their network and expertise to help founders succeed.

Next Gear Ventures (NGV) is an early-stage venture capital fund based in Tel Aviv, focused on investing in smart mobility, energy, and sustainability sectors. The firm primarily targets Israeli startups but also supports companies in Europe and the U.S. NGV is dedicated to nurturing world-changing innovations, emphasizing ventures that contribute to a greener, safer future for transportation. NGV is known for more than just providing capital; they offer a comprehensive ecosystem of resources and connections through their partnership with Drive TLV, an innovation hub that accelerates the growth of startups in the smart mobility space. This partnership allows NGV-backed companies to gain valuable market insights and strategic connections early on, enhancing their chances of success. The fund has a track record of successful exits, including companies like Midnight Robotics and Exo Technologies. NGV typically invests between $100,000 and $2.5 million in early-stage companies, focusing on building long-term partnerships with founders rather than seeking quick exits. Their investments prioritize finding product-market fit and scaling solutions with global impact, particularly in sectors that improve the quality of life and environmental sustainability​.

Credit Suisse Entrepreneur Capital Ltd., established in 2010, is the venture capital arm of Credit Suisse based in Zurich, Switzerland. The firm focuses on investing in innovative small and medium-sized enterprises (SMEs) and startups across various sectors, including robotics, automation, medtech, and fintech. To date, Credit Suisse Entrepreneur Capital has invested around CHF 130 million in over 50 companies, and recently expanded its fund by an additional CHF 70 million, bringing the total to CHF 200 million. Notable investments from Credit Suisse Entrepreneur Capital include Perspective Robotics (d.b.a. Fotokite), a Zurich-based startup specializing in tethered drones that improve the safety and efficiency of public safety operations, and Ava, a company in the monitoring equipment sector. These investments highlight the firm’s commitment to supporting high-potential technologies and innovative business models. Credit Suisse's venture capital efforts are part of a broader strategy to support Switzerland's entrepreneurial ecosystem, ensuring the country remains a global leader in innovation and business. For more information about their investments and strategic approach, you can visit their official website.

Next Level Ventures (NLV) is Iowa's largest and most prominent strategic investment firm, founded in 2014 and headquartered in Des Moines. The firm is led by Founder and Managing Partner Craig Ibsen, who brings more than 25 years of operating experience, previously serving as a senior executive at Maytag Corporation and as the founder of Appliancezone, a global appliance-parts supply-chain software company. The team also includes Managing Partner Michael Perrin, Principal Liz Keehner, and long-tenured COO Barbara Gooch, who built operational infrastructure for Churchill Capital and Northstar Capital over 25 years before joining NLV. Across five funds, NLV manages approximately $500 million to $700 million in assets and a portfolio of roughly 45 to 50 companies. Three of those funds target Iowa startups specifically through the Iowa Fund series, while others support broader themes — the Curql Fund, for example, delivers fintech solutions to credit unions nationwide. NLV writes checks from $500,000 to $5 million into companies approaching or at product-market fit raising rounds of $1 million to $4 million, with a strong Midwest bias across agtech, data analytics, fintech, healthtech, IoT, SaaS, and AI. In January 2025 NLV launched Fund III, its fifth vehicle overall and third Iowa-focused fund, with the inaugural investment from that vehicle deployed into Genvax Technologies, an Ames, Iowa biotechnology company, in February 2025. A notable portfolio exit is the acquisition of Tractor Zoom by Anvil App Works. NLV's deep roots in the Iowa entrepreneurial community, combined with its multi-fund scale, position it as both the most active investor and the most connected network in the state's emerging technology ecosystem.

Next Orbit Ventures Fund-I (NOVF) is a Mumbai-based early- and growth-stage venture capital and multi-asset fund manager founded in 2012, led by Founder and Managing Partner Ajay Jalan — a senior dealmaker widely recognised as an architect of India's investment push into semiconductor manufacturing and the broader Electronics System Design and Manufacturing (ESDM) ecosystem. The firm oversees roughly $10 billion of targeted investments across five funds; its Second Fund carried a target corpus of $750 million, and the firm has separately announced a $2 billion capital raise focused on India's semiconductor and electronics industries. The thesis is to position India as the world's preferred ESDM destination, forecasting an $810 billion Indian electronics market. NOVF's most visible initiative is leading the International Semiconductor Consortium (ISMC) in a joint venture with Israel's Tower Semiconductor, which signed a Rs 22,900 crore (approximately $3 billion) MoU to establish a greenfield chip-fabrication plant in Mysuru, Karnataka pending Government of India approval. The fund leads rounds and writes checks spanning from $1 million to more than $50 million across hardware and robotics, deep tech, fintech, healthtech, and consumer electronics. The portfolio comprises roughly 18 companies with seven IPOs and one acquisition. Headline names include Thyrocare Technologies, India's first fully automated diagnostic laboratory, acquired by API Holdings for $613 million in June 2021; RBL Bank, dual-listed on BSE and NSE at approximately $1.25 billion market cap; and Infibeam Avenues. The most recent disclosed exit was Mercator Group in December 2024. NOVF's focus on strategic national infrastructure — semiconductors, electronics manufacturing, and diagnostics — distinguishes it from conventional venture funds and gives it direct access to government policy frameworks and industrial-scale capital deployment.

Next Play Capital is a minority-owned venture capital firm based in Redwood City, California, with a unique focus on investing in access-constrained venture funds and venture-backed companies across various sectors, including consumer, fintech, and IT/SaaS. Since its founding in 2014 by former NFL athletes and seasoned tech investors, the firm has grown to manage over $450 million in assets. Its strength lies in leveraging a diverse network of professional athletes, GPs, entrepreneurs, and entertainers, which provides access to high-level venture opportunities that are typically closed off to most investors. Next Play Capital operates both through flagship funds and 24 special purpose vehicles (SPVs) to execute direct investments in venture-backed companies. The firm’s portfolio includes partnerships with top-tier venture funds and companies, boasting 54 investments and strong relationships with 34 general partners. With a strategic, long-term approach, the firm remains sector-agnostic but focuses heavily on technology and innovation-driven companies. Recent investments include participation in high-profile rounds for companies like Impossible Foods and Guild Education. Founded by Ryan Nece, Next Play Capital emphasizes empowerment, community, and providing resources to traditionally underserved communities. Their annual Bridge Summit serves as a platform for connecting leaders from sports, entertainment, and venture capital, creating a powerful network for idea exchange and investment opportunities. The firm's mission is to democratize access to venture capital and support innovative founders who are shaping the future​.

Next Play Ventures is a venture capital firm founded in 2020 by Jeff Weiner, the former CEO of LinkedIn, with a mission to coach and invest in entrepreneurial leaders building world-class, purpose-driven companies. Weiner is joined by Managing Director Brian Rumao, his former chief of staff. The firm takes a unique approach by blending investment with coaching, helping founders not only grow their businesses but also develop strong leadership skills rooted in compassion and values. The firm’s philosophy centers on the idea that doing well and doing good are not mutually exclusive. Next Play Ventures focuses on early-stage investments, primarily in industries like SaaS, fintech, healthtech, education, and productivity software. Notable portfolio companies include Figma, Brex, Scale, and Common Room. The firm also emphasizes social impact, with a commitment to closing the opportunity gap for underserved communities through initiatives like the Boys & Girls Clubs of the Peninsula and The Compassion Project. The name "Next Play" is inspired by legendary basketball coach Mike Krzyzewski’s philosophy of focusing on the next move, whether in victory or defeat. This reflects Next Play’s commitment to helping founders continually move forward, learning from both successes and failures. By providing a blend of capital and mentorship, Next Play Ventures aims to cultivate resilient, impactful companies and leaders for the long term.

NEXT VENTURES is an early-stage venture capital firm founded in 2019 by seven-time Tour de France winner Lance Armstrong, with offices in Austin, Texas and San Francisco. The firm invests exclusively in companies addressing 'whole person health' — a portfolio spanning sports and fitness, outdoor and endurance, nutrition and wellness, preventive care, and diagnostics. Co-founder Armstrong is joined by General Partner Lionel Conacher, an experienced operator and investor, and Founding Partner Melanie Strong, who focuses on innovative technology investments across health, wellness, and sports. NEXT currently manages roughly $60 million in AUM and has launched a $100 million Fund II to double down on whole-person health, preventive care, and diagnostics. Typical initial checks range from $1 million to $3 million at seed and Series A into revenue-producing, market-validated companies. The portfolio includes 18 companies and has produced 1 unicorn, 3 acquisitions, and several notable portfolio companies. The standout holding is Oura, the smart-ring health-wearable leader that reached unicorn status. Other portfolio names include Humane, an AI wearable company; Genopets, a move-to-earn game; Amp Human, which makes PR Lotion and merged with Momentous; PowerDot, a muscle-recovery technology; Pair Team, a preventive-care platform; Vital BioSciences; and Trial Library. Recent acquisitions include SteadyMD, acquired by DocGo in October 2025, and Hammerhead, acquired by SRAM in January 2022. NEXT VENTURES' sector focus is genuinely differentiated: by concentrating on the intersection of health span, athletic performance, and consumer wellness, the firm accesses a market that most traditional healthcare or consumer VCs approach only partially. The founders' operational networks in endurance sport and fitness provide a sourcing advantage that few funds can replicate.

Next47, the global venture capital arm of Siemens, focuses on investing in early and expansion-stage enterprise tech startups. With a presence in Palo Alto, Berlin, Tel Aviv, London, Munich, and Paris, Next47 specializes in sectors like SaaS, AI, and enterprise technology. Their portfolio boasts notable companies such as Verkada, Skydio, and ChargePoint, reflecting their expertise in backing high-potential tech ventures. Next47's investment strategy emphasizes deep engagement with portfolio companies, providing strategic advice, connections, and resources to help them scale. They lead funding rounds with average check sizes varying based on the stage and requirements of the startup. The firm prides itself on a long-term partnership approach, ensuring consistent support through every growth phase. The fund is highly active, with a robust network of 250+ customers across 15 countries, enabling startups to accelerate their go-to-market strategies and secure significant bookings. Founders benefit from Next47's extensive talent network, assisting in making critical hires and developing executive recruiting strategies. Key team members include Lak Ananth, CEO and Managing Partner, and T.J. Rylander, General Partner, both based in Palo Alto. Their combined experience in venture capital and enterprise tech provides invaluable guidance to startups navigating complex growth trajectories. Next47’s global reach and strategic focus make it a vital player in the enterprise tech venture capital landscape, committed to driving innovation and supporting founders in building the next generation of category-leading companies.